RxDoctor Payments DataLook up a doctor →

Amy Stewart, NP

Family · Washington, DCNPI 1568992766

Payments from drug & device makers

$488,599in general payments, 2019–2025

Across 1,440 payments — averaging $339.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$169K
  • Phathom Pharmaceuticals, Inc.$60K
  • Lilly USA, LLC$52K
  • Pfizer$47K
  • E.r. Squibb & Sons, L.L.C.$45K
  • Takeda Pharmaceuticals U.S.A., Inc.$35K
  • plus $81K from 30 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson278$169,246
Phathom Pharmaceuticals, Inc.121$60,175
Lilly USA, LLC119$51,579
Pfizer109$46,513
E.r. Squibb & Sons, L.L.C.98$45,364
Takeda Pharmaceuticals U.S.A., Inc.88$35,199
Celltrion USA Inc.43$19,041
Ferring Pharmaceuticals Inc.47$9,554
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC87$9,108
Bristol Myers Squibb133$8,261
Janssen Scientific Affairs, LLC29$7,779
Exact Sciences21$7,572
Eli Lilly13$6,782
AbbVie86$3,600
Regeneron Healthcare Solutions, Inc.19$1,765
Sanofi31$1,589
Ardelyx, Inc.38$1,371
Regeneron2$1,310
Aimmune Therapeutics, Inc.16$543
Merck4$357
Boston Scientific4$257
Boehringer Ingelheim8$243
Amgen5$225
Daiichi Sankyo Inc.9$218
QOL Medical, LLC4$131
Intercept Pharmaceuticals, Inc.5$124
Therapeuticsmd, Inc.1$123
Braintree Laboratories, Inc.6$121
Biohaven Pharmaceuticals, Inc.1$112
Novo Nordisk3$59
Ironwood Pharmaceuticals, Inc3$58
Evofem Biosciences, Inc.1$56
Ipsen Biopharmaceuticals, Inc2$51
Nestle Healthcare Nutrition Inc.2$46
Sandoz2$34
Evoke Pharma, Inc.2$33

How this compares

$488,599 in reported general payments places this provider in the 95th percentile of 392 family providers in District of Columbia.

See all family providers in District of Columbia →

Medicare billing

Part B allowed, 2024
$20,914
Medicare patients
115
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →